Insulin-Like Growth Factor Binding Protein 3

"Insulin-Like Growth Factor Binding Protein 3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

One of the six homologous soluble proteins that bind insulin-like growth factors (SOMATOMEDINS) and modulate their mitogenic and metabolic actions at the cellular level.

Descriptor ID	D018972
MeSH Number(s)	D12.776.157.420.270
Concept/Terms	Insulin-Like Growth Factor Binding Protein 3 Insulin-Like Growth Factor Binding Protein 3 IGF-Binding Protein 3 IGF Binding Protein 3 Protein 3, IGF-Binding IGFBP-3

Below are MeSH descriptors whose meaning is more general than "Insulin-Like Growth Factor Binding Protein 3".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Carrier Proteins [D12.776.157]
Insulin-Like Growth Factor Binding Proteins [D12.776.157.420]
Insulin-Like Growth Factor Binding Protein 3 [D12.776.157.420.270]

Below are MeSH descriptors whose meaning is related to "Insulin-Like Growth Factor Binding Protein 3".

Below are MeSH descriptors whose meaning is more specific than "Insulin-Like Growth Factor Binding Protein 3".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Insulin-Like Growth Factor Binding Protein 3" by people in this website by year, and whether "Insulin-Like Growth Factor Binding Protein 3" was a major or minor topic of these publications.

Bar chart showing 9 publications over 6 distinct years, with a maximum of 3 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	0	1	1
2006	0	2	2
2008	0	1	1
2009	0	1	1
2011	2	1	3
2019	0	1	1

Below are the most recent publications written about "Insulin-Like Growth Factor Binding Protein 3" by people in Profiles.

Crew KD, Anderson GL, Hershman DL, Terry MB, Tehranifar P, Lew DL, Yee M, Brown EA, Kairouz SS, Kuwajerwala N, Bevers T, Doster JE, Zarwan C, Kruper L, Minasian LM, Ford L, Arun B, Neuhouser M, Goodman GE, Brown PH. Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812). Cancer Prev Res (Phila). 2019 07; 12(7):481-490.

View in: PubMed
Switkowski KM, Jacques PF, Must A, Hivert MF, Fleisch A, Gillman MW, Rifas-Shiman S, Oken E. Higher Maternal Protein Intake during Pregnancy Is Associated with Lower Cord Blood Concentrations of Insulin-like Growth Factor (IGF)-II, IGF Binding Protein 3, and Insulin, but Not IGF-I, in a Cohort of Women with High Protein Intake. J Nutr. 2017 07; 147(7):1392-1400.

View in: PubMed
Yamauchi J, Kumar A, Duarte L, Mehuron T, Girgenrath M. Triggering regeneration and tackling apoptosis: a combinatorial approach to treating congenital muscular dystrophy type 1 A. Hum Mol Genet. 2013 Nov 01; 22(21):4306-17.

View in: PubMed
McLaughlin JM, Olivo-Marston S, Vitolins MZ, Bittoni M, Reeves KW, Degraffinreid CR, Schwartz SJ, Clinton SK, Paskett ED. Effects of tomato- and soy-rich diets on the IGF-I hormonal network: a crossover study of postmenopausal women at high risk for breast cancer. Cancer Prev Res (Phila). 2011 May; 4(5):702-10.

View in: PubMed
Nwosu BU, Soyka LA, Angelescu A, Lee MM. Evidence of insulin-like growth factor binding protein-3 proteolysis during growth hormone stimulation testing. J Pediatr Endocrinol Metab. 2011; 24(3-4):163-7.

View in: PubMed
Sturgeon SR, Volpe SL, Puleo E, Bertone-Johnson ER, Heersink J, Sabelawski S, W?h?l? K, Bigelow C, Kurzer MS. Dietary intervention of flaxseed: effect on serum levels of IGF-1, IGF-BP3, and C-peptide. Nutr Cancer. 2011; 63(3):376-80.

View in: PubMed
Quintos JB, Grover M, Boney CM, Salas M. Autoimmune polyglandular syndrome Type 3 and growth hormone deficiency. Pediatr Diabetes. 2010 Sep; 11(6):438-42.

View in: PubMed
Krause JC, Toye MP, Fisher DJ, Stechenberg BW, Reiter EO, Allen HF. Metabolic abnormalities in human immunodeficiency virus-infected children: two-year follow-up. J Pediatr Endocrinol Metab. 2009 Apr; 22(4):345-51.

View in: PubMed
Mathews L, Schneider SS. Insulin-like growth factor-I inhibits growth regulatory responses engaged by estrogen and progesterone in the mouse mammary gland. Eur J Cancer Prev. 2008 Aug; 17(4):297-305.

View in: PubMed
Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev. 2006 May; 15(5):972-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals